148 related articles for article (PubMed ID: 8002527)
1. Reversal of pulmonary capillary ischemia-reperfusion injury by rolipram, a cAMP phosphodiesterase inhibitor.
Barnard JW; Seibert AF; Prasad VR; Smart DA; Strada SJ; Taylor AE; Thompson WJ
J Appl Physiol (1985); 1994 Aug; 77(2):774-81. PubMed ID: 8002527
[TBL] [Abstract][Full Text] [Related]
2. Reversal of increased microvascular permeability associated with ischemia-reperfusion: role of cAMP.
Seibert AF; Thompson WJ; Taylor A; Wilborn WH; Barnard J; Haynes J
J Appl Physiol (1985); 1992 Jan; 72(1):389-95. PubMed ID: 1311292
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4).
Thompson WJ; Ashikaga T; Kelly JJ; Liu L; Zhu B; Vemavarapu L; Strada SJ
Biochem Pharmacol; 2002 Feb; 63(4):797-807. PubMed ID: 11992650
[TBL] [Abstract][Full Text] [Related]
4. Reduced ischemia-reperfusion injury with rolipram in rat cadaver lung donors: effect of cyclic adenosine monophosphate.
Bleiweis MS; Jones DR; Hoffmann SC; Becker RM; Egan TM
Ann Thorac Surg; 1999 Jan; 67(1):194-9; discussion 199-200. PubMed ID: 10086548
[TBL] [Abstract][Full Text] [Related]
5. Rolipram and isoproterenol reverse platelet activating factor-induced increases in pulmonary microvascular permeability and vascular resistance.
Noel PE; Fletcher JR; Thompson WJ
J Surg Res; 1995 Jul; 59(1):159-64. PubMed ID: 7630121
[TBL] [Abstract][Full Text] [Related]
6. Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4.
Miotla JM; Teixeira MM; Hellewell PG
Am J Respir Cell Mol Biol; 1998 Mar; 18(3):411-20. PubMed ID: 9490659
[TBL] [Abstract][Full Text] [Related]
7. Maintenance of cAMP in non-heart-beating donor lungs reduces ischemia-reperfusion injury.
Hoffmann SC; Bleiweis MS; Jones DR; Paik HC; Ciriaco P; Egan TM
Am J Respir Crit Care Med; 2001 Jun; 163(7):1642-7. PubMed ID: 11401888
[TBL] [Abstract][Full Text] [Related]
8. The pharmacodynamic action of the cyclic AMP phosphodiesterase inhibitor rolipram on prolactin producing rat pituitary adenoma (GH4C1) cells.
Gordeladze JO
Biosci Rep; 1990 Aug; 10(4):375-88. PubMed ID: 2174276
[TBL] [Abstract][Full Text] [Related]
9. Subthreshold doses of nebulized prostacyclin and rolipram synergistaically protect against lung ischemia-reperfusion.
Schütte H; Schell A; Schäfer C; Ghofrani A; Theo Schermuly R; Seeger W; Grimminger F
Transplantation; 2003 Mar; 75(6):814-21. PubMed ID: 12660508
[TBL] [Abstract][Full Text] [Related]
10. Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capillary injury.
Adkins WK; Barnard JW; May S; Seibert AF; Haynes J; Taylor AE
J Appl Physiol (1985); 1992 Feb; 72(2):492-7. PubMed ID: 1313790
[TBL] [Abstract][Full Text] [Related]
11. Isoprenaline induction of cAMP-phosphodiesterase in guinea-pig macrophages occurs in the presence, but not in the absence, of the phosphodiesterase type IV inhibitor rolipram.
Kochetkova M; Burns FM; Souness JE
Biochem Pharmacol; 1995 Dec; 50(12):2033-8. PubMed ID: 8849330
[TBL] [Abstract][Full Text] [Related]
12. Sequential alterations of [3H]rolipram and [3H]cyclic adenosine monophosphate binding in the gerbil brain following transient cerebral ischemia.
Murase K; Kato H; Araki T; Kogure K
Brain Res; 1993 Feb; 602(2):234-9. PubMed ID: 8383573
[TBL] [Abstract][Full Text] [Related]
13. Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury.
Souza DG; Cassali GD; Poole S; Teixeira MM
Br J Pharmacol; 2001 Nov; 134(5):985-94. PubMed ID: 11682446
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
Torphy TJ; Zhou HL; Cieslinski LB
J Pharmacol Exp Ther; 1992 Dec; 263(3):1195-205. PubMed ID: 1335058
[TBL] [Abstract][Full Text] [Related]
15. Inhaled nitric oxide pretreatment but not posttreatment attenuates ischemia-reperfusion-induced pulmonary microvascular leak.
Chetham PM; Sefton WD; Bridges JP; Stevens T; McMurtry IF
Anesthesiology; 1997 Apr; 86(4):895-902. PubMed ID: 9105234
[TBL] [Abstract][Full Text] [Related]
16. Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition.
Okusa MD; Linden J; Huang L; Rosin DL; Smith DF; Sullivan G
Kidney Int; 2001 Jun; 59(6):2114-25. PubMed ID: 11380813
[TBL] [Abstract][Full Text] [Related]
17. Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats.
Zhang HT; O'Donnell JM
Psychopharmacology (Berl); 2000 Jun; 150(3):311-6. PubMed ID: 10923759
[TBL] [Abstract][Full Text] [Related]
18. The short-term activation of a rolipram-sensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation.
Sette C; Iona S; Conti M
J Biol Chem; 1994 Mar; 269(12):9245-52. PubMed ID: 8132662
[TBL] [Abstract][Full Text] [Related]
19. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3',5'-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung.
Haynes J; Killilea DW; Peterson PD; Thompson WJ
J Pharmacol Exp Ther; 1996 Feb; 276(2):752-7. PubMed ID: 8632346
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells.
Matousovic K; Grande JP; Chini CC; Chini EN; Dousa TP
J Clin Invest; 1995 Jul; 96(1):401-10. PubMed ID: 7615811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
